Optase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Optase
Generic name
GLYCERIN
Manufacturer
Scope Health Inc
Product type
HUMAN OTC DRUG
SPL set ID
10c3e31d-779d-8ff6-e063-6294a90acd39
SPL ID
49a2fdf9-1bd1-56de-e063-6294a90afdda
Version
4
Effective date
2026-01-30
Source export date
2026-09-28
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/f7d2b6e3f8600cd856280ab55a9c6fa54a642647191d164f9d1110e89f3f4097/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:14:58
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning • For external use only. • To avoid contamination, do not touch tip of container to any surface. • If solution changes color or becomes cloudy, do not use. • Do not use a damaged or punctured single-dose container. • Wait at least 15 minutes between possible applications of other ophthalmic medication. • Use immediately once opened. • Do not reuse. Discard any remaining solution after use. • Do not use if you are sensitive to any of the ingredients. • Do not use after the expiry date shown on the pack.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.